Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
G. Willi-Food International
WILC
$385M
| $2.49M | 0.01% |
596,900
+13,400
| +2% | +$54.8K |
|
|
EGIO
1977
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.49M | 0.01% |
42,596
-2,631
| -6% | -$196K |
|
1978
German American Bancorp
GABC
$1.91B
| $2.48M | 0.01% |
111,450
-900
| -0.8% | -$19.4K |
|
1979
RB Global
RBA
$16B
| $2.47M | 0.01% |
102,344
+544
| +0.5% | +$14K |
|
|
KITE
1980
DELISTED
Kite Pharma, Inc.
KITE
| $2.47M | 0.01% |
+40,013
| New | +$2.82M |
|
1981
LSB Industries
LXU
$711M
| $2.46M | 0.01% |
441,870
+80,964
| +22% | +$668K |
|
|
ALSK
1982
DELISTED
Alaska Communications Systems
ALSK
| $2.46M | 0.01% |
1,406,884
+190,944
| +16% | +$400K |
|
|
STB
1983
DELISTED
Student Transportation Inc
STB
| $2.46M | 0.01% |
663,100
+57,600
| +10% | +$232K |
|
1984
City Holding Co
CHCO
$2.07B
| $2.45M | 0.01% |
53,737
+23,037
| +75% | +$1.11M |
|
1985
Powell Industries
POWL
$7.58B
| $2.45M | 0.01% |
282,000
+153,900
| +120% | +$1.6M |
|
|
XCO
1986
DELISTED
Exco Resources
XCO
| $2.45M | 0.01% |
131,547
+98,234
| +295% | +$1.62M |
|
1987
Alico
ALCO
$308M
| $2.44M | 0.01% |
63,091
+4,400
| +7% | +$183K |
|
|
INTX
1988
DELISTED
Intersections, Inc.
INTX
| $2.44M | 0.01% |
850,500
+21,700
| +3% | +$51.8K |
|
1989
Revvity
RVTY
$13.2B
| $2.44M | 0.01% |
45,500
-345,900
| -88% | -$17.6M |
|
1990
1st Source
SRCE
$2.13B
| $2.43M | 0.01% |
78,708
+12,294
| +19% | +$394K |
|
1991
Stryker
SYK
$133B
| $2.43M | 0.01% |
+26,100
| New | +$2.5M |
|
1992
Wells Fargo
WFC
$269B
| $2.42M | 0.01% |
+44,556
| New | +$2.42M |
|
1993
Ally Financial
ALLY
$13.6B
| $2.41M | 0.01% |
+129,400
| New | +$2.56M |
|
1994
Nucor
NUE
$61.7B
| $2.41M | 0.01% |
+59,800
| New | +$2.46M |
|
1995
AeroVironment
AVAV
$9.59B
| $2.4M | 0.01% |
81,600
-175,736
| -68% | -$4.31M |
|
|
ITCI
1996
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.4M | 0.01% |
44,700
-138,391
| -76% | -$6.98M |
|
|
TRQ
1997
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $2.4M | 0.01% |
94,464
+52,490
| +125% | +$1.42M |
|
|
PGRE
1998
DELISTED
Paramount Group
PGRE
| $2.39M | 0.01% |
132,200
+119,800
| +966% | +$2.14M |
|
|
ENZN
1999
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
| $2.39M | 0.01% |
3,501,585
-38,499
| -1% | -$30.5K |
|
|
LKFT
2000
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
| $2.38M | 0.01% |
+37,900
| New | +$1.94M |
|
Similar funds
Jim Simons's Q4 2015 Portfolio in Review
As of Q4 2015, Jim Simons held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Jim Simons deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Jim Simons's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Jim Simons added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Jim Simons's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Jim Simons fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Jim Simons's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Jim Simons opened 509 new positions and closed 386 in Q4 2015.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.